Document is current
Any future updates will be listed below
-
Authors
Öcal, Osman
Kupčinskas, Juozas
Morkunas, Egidijus
Amthauer, Holger
Schütte, Kerstin
Malfertheiner, Peter
Klümpen, Heinz Josef
Sengel, Christian
Benckert, Julia
Seidensticker, Ricarda
Sangro, Bruno
Wildgruber, Moritz
Pech, Maciej
Bartenstein, Peter
Ricke, Jens
Seidensticker, Max https://orcid.org/0000-0002-2481-5410
-
Funding
Funding for this research was provided by:
Sirtex
Bayer HealthCare
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 3 March 2021
Accepted: 17 May 2021
First Online: 2 June 2021
Declarations
:
: The study protocol was approved by the institutional review boards of each participating center, and competing authorities.
: All patients gave written informed consent for study participation.
: Holger Amthauer: Grants: Sirtex, Bayer. Personal fees: Sirtex, GE Healthcare, Novartis, outside the submitted work. Kerstin Schütte: Personal fees: Bayer. Peter Malfertheiner: Grants: Bayer, Sirtex. Heinz Josef Klümpen: Grants: Bayer, Personal fees: Ipsen, outside the submitted work. Bruno Sangro: Personal fees: Sirtex, BTG, Bayer, BMS, Astra Zeneca, Eli Lilly, Merck, Novartis, Terumo, Adaptimmune; Non-financial support: Sirtex, BMS, outside the submitted work. Maciej Pech: Grants: Sirtex, Bayer; Personal fees: Sirtex. Peter Bartenstein: Grants: Sirtex. Jens Ricke: Grants: Sirtex, Bayer; Personal fees: Sirtex, Bayer. Max Seidensticker: Personal fees: Bayer, Sirtex.
